NBI-1065845 for depression
This study is recruiting in the United States. It is testing NBI-1065845 for depression.
Multiple locations, including Huntsville
Public study records, presented in a clearer and more patient-friendly format for mental health research discovery.
This study is recruiting in the United States. It is testing NBI-1065845 for depression.
Multiple locations, including HuntsvilleThis study is recruiting in the United States, in Canada, in the United Kingdom, .... It is testing NBI-1065845 for depression.
Multiple locations, including ChinoThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In San FranciscoThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In BrooklynThis study is recruiting. It focuses on depression and currently lists participation information in the Netherlands.
In NetherlandsThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
Multiple locations, including MiamiThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In New YorkThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In BelmontThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
Multiple locations, including BostonThis study is recruiting. It focuses on depression and currently lists participation information in China.
In ShanghaiThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
In TulsaThis study is recruiting. It focuses on depression and currently lists participation information in the United States.
Multiple locations, including BirminghamHopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.